• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Director Claffee Lily Fu was granted 3,733 shares, increasing direct ownership by 10% to 42,917 units (SEC Form 4)

    6/3/25 3:06:00 PM ET
    $JXN
    Life Insurance
    Finance
    Get the next $JXN alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Claffee Lily Fu

    (Last) (First) (Middle)
    1 CORPORATE WAY

    (Street)
    LANSING MI 48951

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Jackson Financial Inc. [ JXN ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    06/01/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock(1) 06/01/2025 A 2,228 A $0.00 41,411.74 D
    Common Stock(2) 06/01/2025 A 1,505 A $0.00 42,916.74 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Reflects restricted share units ("RSUs") granted on June 1, 2025, as part of the 2025-2026 Annual Director Compensation. The RSUs cliff vest on June 1, 2026, or the next Annual Meeting of Shareholders, whichever comes first. Vested RSUs settle in common stock on a one-for-one basis upon the Director's end of service and any fractional shares will be paid in cash.
    2. Reflects restricted share units ("RSUs") granted on June 1, 2025, where the Director elected to receive equity in lieu of the cash portion of the 2025-2026 Annual Director Compensation. The RSUs vest in four equal tranches on August 31, 2025, November 30, 2025, February 28, 2026, and May 31, 2026. Vested RSUs settle in common stock on a one-for-one basis upon the Director's end of service and any fractional shares will be paid in cash.
    Remarks:
    Power of Attorney on file.
    /s/ Kristan L. Richardson, as Attorney-in-Fact 06/03/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $JXN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $JXN

    DatePrice TargetRatingAnalyst
    11/14/2024$74.00 → $95.00In-line → Underperform
    Evercore ISI
    9/5/2024$109.00Overweight
    Barclays
    5/14/2024Outperform → Mkt Perform
    Keefe Bruyette
    2/28/2024$49.00 → $68.00Mkt Perform → Outperform
    Keefe Bruyette
    1/2/2024$55.00Buy → Hold
    Jefferies
    3/3/2022$40.00 → $42.00Equal-Weight
    Morgan Stanley
    1/26/2022$52.00Buy
    Jefferies
    1/7/2022$38.00 → $40.00Equal-Weight
    Morgan Stanley
    More analyst ratings

    $JXN
    SEC Filings

    See more
    • Jackson Financial Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - Jackson Financial Inc. (0001822993) (Filer)

      5/27/25 5:20:36 PM ET
      $JXN
      Life Insurance
      Finance
    • SEC Form 13F-NT filed by Jackson Financial Inc.

      13F-NT - Jackson Financial Inc. (0001822993) (Filer)

      5/13/25 7:46:15 AM ET
      $JXN
      Life Insurance
      Finance
    • Jackson Financial Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Jackson Financial Inc. (0001822993) (Filer)

      5/7/25 4:26:20 PM ET
      $JXN
      Life Insurance
      Finance